HC Wainwright & Co. Reiterates Neutral on CareDx
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Neutral rating on CareDx (NASDAQ:CDNA).

August 01, 2024 | 1:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Yi Chen has reiterated a Neutral rating on CareDx (NASDAQ:CDNA). This suggests that the analyst does not foresee significant short-term changes in the stock's performance.
The reiteration of a Neutral rating by HC Wainwright & Co. suggests that the analyst does not expect significant short-term movements in CareDx's stock price. This rating indicates a hold position, implying that the stock is expected to perform in line with the market.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100